By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferring B.V. 

Polaris Avenue 144, Hoofddorp

Noord-Holland    2132 JX  The Netherlands
Phone: 31-23-554-0550 Fax: 31-23-5680-390



Company News
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015 6:49:51 AM
Ferrer Internacional Initiates Phase III Clinical Studies for Novel Antibacterial Compound, Ozenoxacin, in Development as a Topical Treatment for Impetigo and Other Infectious Dermatological Conditions 1/19/2012 10:27:03 AM
CepTor Corporation (CEPO.OB) Executes LOI With Ferring For Late Stage Product; Superoxide Dismutase Targeted For Phase 2B Clinical Trials 9/15/2006 9:57:37 AM
Savient Pharmaceuticals, Inc. (SVNT) To Sell Global Biologics Manufacturing Business For $80 Million To Ferring Holding SA; Major Milestone Achieved In Savient's New Strategic Direction10/19/2005 5:13:06 PM
Savient Pharmaceuticals, Inc. (SVNT) Enters Co-Promotion Agreement With Ferring Pharmaceuticals, Inc. For Nuflexxa; Savient To Establish Sales Force Targeting Rheumatologists Upon Sale Of Global Biologics Manufacturing Business10/19/2005 5:13:06 PM
Savient Pharmaceuticals, Inc. (SVNT) Provides Update On Closing Of Sale Of Global Biologics Manufacturing Business To Ferring B.V.10/19/2005 5:09:21 PM